A 2-year, multicenter, placebo-controlled, double-blind, parallel-group study of the effect of riluzole on Parkinson's disease progression

被引：0
|
作者：
Rascol, O
Olanow, W
Brooks, D
Koch, G
Truffinet, P
Bejuit, R
机构：
来源：
MOVEMENT DISORDERS | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P80
引用
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [1] A double-blind, placebo-controlled and longitudinal study of riluzole in early Parkinson's disease
    Jankovic, J
    Hunter, C
    PARKINSONISM & RELATED DISORDERS, 2002, 8 (04) : 271 - 276
  • [2] Clinical evaluation of pramipexole in advanced Parkinson's disease: Results of a double-blind, placebo-controlled, parallel-group study
    Lieberman, A
    Ranhosky, A
    Korts, D
    NEUROLOGY, 1997, 49 (01) : 162 - 168
  • [3] Donepezil in patients with severe Alzheimer's disease:: double-blind, parallel-group, placebo-controlled study
    Winblad, B
    Kilander, L
    Eriksson, S
    Minthon, L
    Båtsman, S
    Wetterholm, AL
    Jarisson-Blixt, C
    Hoglund, A
    LANCET, 2006, 367 (9516): : 1057 - 1065
  • [4] Efficacy of Zhengtian Pill for migraine prophylaxis: A randomized, multicenter, double-blind, placebo-controlled, parallel-group study
    Cao, Kegang
    Yu, Lihua
    Gao, Ying
    Fan, Yongping
    Zhao, Jianjun
    Zhang, Xuezhi
    Xie, Wei
    Yang, Wenming
    Dong, Mengjiu
    Li, Tao
    Qiao, Xiangyang
    EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2014, 6 (03) : 259 - 267
  • [5] Treatment of partial seizures with gabapentin: Double-blind, placebo-controlled, parallel-group study
    Yamauchi, Toshio
    Kaneko, Sunao
    Yagi, Kazuichi
    Sase, Shinichi
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2006, 60 (04) : 507 - 515
  • [6] Effect of riluzole on dyskinesia and duration of the ON state in Parkinson disease patients - A double-blind placebo-controlled pilot study
    Braz, CA
    Borges, V
    Ferraz, HB
    CLINICAL NEUROPHARMACOLOGY, 2004, 27 (01) : 25 - 29
  • [7] Secukinumab in Giant Cell Arteritis: A Randomized, Parallel-group, Double-blind, Placebo-controlled, Multicenter Phase 2 Trial
    Venhoff, Nils
    Schmidt, Wolfgang
    Bergner, Raoul
    Rech, Juergen
    Unger, Leonore
    Tony, Hans-Peter
    Mendelson, Meryl
    Sieder, Christian
    Maricos, Meron
    Thiel, Jens
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 4130 - 4133
  • [8] Transdermal selegiline in major depression: A double-blind, placebo-controlled, parallel-group study in outpatients
    Bodkin, JA
    Amsterdam, JD
    AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (11): : 1869 - 1875
  • [9] Lamotrigine for painful polyneuropathy: Randomized, placebo-controlled, double-blind, parallel-group pilot study
    Hart, DE
    Riback, PS
    Calder, CS
    Storey, JR
    Wymer, JP
    Potter, DL
    ANNALS OF NEUROLOGY, 2001, 50 (03) : S35 - S35
  • [10] Minimal Disease Activity Among Active Psoriatic Arthritis Patients Treated With Secukinumab: 2-Year Results From a Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase III Study
    Coates, Laura C.
    Mease, Philip J.
    Gossec, Laure
    Kirkham, Bruce
    Sherif, Bintu
    Gaillez, Corine
    Mpofu, Shephard
    Jugl, Steffen M.
    Karyekar, Chetan
    Gandhi, Kunal K.
    ARTHRITIS CARE & RESEARCH, 2018, 70 (10) : 1529 - 1535
12345